Celldex Therapeutics, Inc. Share Price
NASDAQ: CLDX | Small CapCelldex Therapeutics, Inc. Stock Performance
Celldex Therapeutics, Inc. Share Price Today
As of 31 October 2026, Celldex Therapeutics, Inc.'s share price is $30.09. The stock opened at $29.90, compared to its previous close of $29.95. During today's trading session, Celldex Therapeutics, Inc.'s share price traded between $29.25 and $30.13, with an average price of $29.69. Over the past 52 weeks, the stock has recorded a high of $45.07 and a low of $22.21. In terms of performance, Celldex Therapeutics, Inc.'s share price has declined by 8.46% over the last six months and is up 12.70% on a year-on-year basis.
Celldex Therapeutics, Inc. Share Price Chart
Celldex Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Celldex Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Celldex Therapeutics, Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Celldex Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $32.16 | $30.11 | -7.41% |
Sep 2026 | $39.22 | $32.52 | -19.52% |
Aug 2026 | $37.93 | $40.40 | +6.12% |
Jul 2026 | $37.35 | $38.07 | +2.41% |
Jun 2026 | $30.95 | $37.17 | +18.43% |
May 2026 | $33.43 | $31.39 | -4.50% |
Apr 2026 | $32.12 | $32.87 | +3.67% |
Mar 2026 | $29.72 | $31.70 | +5.30% |
Feb 2026 | $24.59 | $30.11 | +22.25% |
Jan 2026 | $27.03 | $24.63 | -9.32% |
Dec 2025 | $26.48 | $27.16 | +0.56% |
Nov 2025 | $26.63 | $27.01 | +1.16% |